CRISPR Therapeutics AGCRSPNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average, slight contraction.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-123.71%
↓ 23% below average
Average (9y)
-100.45%
Historical baseline
Range
High:193.95%
Low:-530.08%
CAGR
-8.8%
Structural decline
| Period | Value |
|---|---|
| 2024 | -123.71% |
| 2023 | 76.79% |
| 2022 | -268.21% |
| 2021 | 193.95% |
| 2020 | -530.08% |
| 2019 | 135.76% |
| 2018 | -101.17% |
| 2017 | 9.52% |
| 2016 | -114.77% |
| 2015 | -282.61% |